Guidelines Development Group

The objective of the Guidelines Development Group (GDG) is to develop evidence-based European Guidelines for breast cancer screening and diagnosis for screening and diagnosis.

The GDG will follow the GRADE approach in defining the healthcare question of interest (population of interest, interventions to be compared and patient-relevant outcomes- PICO), synthesizing the evidence and developing the recommendations for the Guidelines. This will be carried out within virtual working environments and in meetings organised every three months.

An external contractor, CCIb –Iberoamerican Cochrane Centre, supports the GDG for their tasks from literature review to drafting of recommendations.

Members and external experts

Sue Warman

Sue Warman

Sue has a BSc (Hons) in Biochemistry.  Her MEd thesis was on the epidemiology of HIV/ AIDS and how the subject is taught in post-16 education.  She also has a Cert Ed (Distinction) and post graduate Coaching qualification.
Early in her career she worked in research planning in the pharmaceutical (Glaxo Research) and food (Rank Hovis McDougall Research) industries (as well as a spell in defence – Marconi Space and Defence Systems) to bring new drugs, food products and defence systems to the market in a timely way.  This work involved liaison between research and development, marketing and production functions and used Operational Research tools.
But most of her career was spent in Further Education, first as a lecturer in health-related subjects and later moving into college management, as Dean of Faculty  and then Director of Curriculum (West Herts College), Deputy Principal (Academic) (South Nottingham College) and finally Vice Principal (Quality and Human Resources) (Milton Keynes College).
For 10 years she also worked as an educational consultant, particularly helping colleges to improve the quality of their post-16 teaching of science subjects.
On retiring, Sue took on a police governance role for 7 years with Hertfordshire Police Authority, where she chaired the Performance Scrutiny Committee.  She currently serves on the Joint Audit Committee of Avon and Somerset’s Police and Crime Commissioner and Constabulary.
At routine NHS mammography screening (late 2012) and follow up assessment (early 2013), Sue was diagnosed with High Grade DCIS.  She declined mastectomy, choosing instead active monitoring, in which she continues currently.  Having read widely about the subject, Sue edited a group submission from “Advocates of Honesty and Transparency in Breast Screening” (a worldwide group of clinicians, researchers, statisticians and informed lay people) to the 2014 Parliamentary Enquiry into Screening.  Several of the group’s concerns were addressed in the recommendations of the Committee’s Report.  Sue has attended the 2014 (Oxford, UK) and 2015 (NIH, Bethesda, USA) Preventing Overdiagnosis Conferences, being awarded a bursary to the second of these.  She has been invited by the Medical Faculty of Bristol University to work with them as a citizen advisor in redesigning the undergraduate medical curriculum to include more clinical reasoning and ethics.  She is committed to the principle of evidence based medicine and to the right of patients to make informed decisions.

Declaration of interests